Inhibition of interleukin-8-activated human neutrophil chemotaxis by thapsigargin in a calcium-and cyclic AMP-dependent way

Biochemical Pharmacology

Volumn 59, Issue 4, 2000, Pages 369-375

  Elferink, Jan G R ^a   De Koster, Ben M ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Calcium; cAMP; Chemotaxis; Neutrophil; Thapsigargin

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 2,5 DI TERT BUTYLHYDROQUINONE; 6 [2 [4 [(4 FLUOROPHENYL)PHENYLMETHYLENE] 1 PIPERIDYL]ETHYL] 7 METHYL 5H THIAZOLO[3,2 A]PYRIMIDIN 5 ONE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE INHIBITOR; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CYCLIC AMP; CYCLOPIAZONIC ACID; DIOCTANOIN; ECONAZOLE; EGTAZIC ACID; GADOLINIUM CHLORIDE; INTERLEUKIN 8; LANTHANUM; LEUKOTRIENE B4; NICKEL; PHORBOL 13 ACETATE 12 MYRISTATE; THAPSIGARGIN; VERAPAMIL;

ARTICLE; CALCIUM CELL LEVEL; CHEMOTAXIS; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL;

CALCIUM; CHEMOTAXIS, LEUKOCYTE; CYCLIC AMP; ENZYME INHIBITORS; HUMANS; INTERLEUKIN-8; NEUTROPHILS; THAPSIGARGIN;

EID: 0033957491     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00342-1     Document Type: Article

References (37)

1. Alteraifi A.M., Zhelev D.V. Transient increase of free cytosolic calcium during neutrophils motility responses. J Cell Sci. 110:1997;1967-1977.
2. Malawista S.E., de Boisfluery Chevance A. Random locomotion and chemotaxis of human blood polymorphonuclear leukocytes (PMN) in the presence of EDTA PMN in close quarters require neither leukocyte integrins nor external divalent cations . Proc Natl Acad Sci USA. 94:1997;11577-11582.
3. Mandeville J.T., Maxfield F.R. Calcium and signal transduction in granulocytes. Currt Opin Hematol. 3:1996;63-70.
4. 2+. Trends Cell Biol. 3:1993;386-391.
5. 2+-handling by non-muscle cells Studies in human neutrophils and HL-60 cells . Cell Calcium. 10:1989;351-361.
6. Lew D.P. Receptor signalling and intracellular calcium in neutrophil activation. Eur J Clin Invest. 19:1989;338-346.
7. 2+-ATPase. Proc Natl Acad Sci USA. 87:1990;2466-2470.
8. 2+-ATPase inhibitor, thapsigargin. Agent Actions. 29:1990;8-15.
9. Törnquist K. Activation of calcium entry by cyclopiazonic acid in thyroid FRTL-5 cells. Cell Calcium. 14:1993;411-417.
10. 2+-releasing mechanisms revealed by manoalide and benzohydroquinone. Biochem J. 279:1991;367-375.
11. 2+ stores and activates an influx pathway for divalent cations in HL-60 cells. J Biol Chem. 267:1992;2318-2324.
12. 2+-ATPase inhibitors 2,5-di-(t-butyl)-1,4-benzohydroquinone and thapsigargin in bovine adrenal chromaffin cells. Biochem J. 288:1992;457-463.
13. 2+ translocase inhibitors thapsigargin and 2,5-di-(t-butyl)-1,4-benzohydroquinone on cellular calcium fluxes. Biochem J. 277:1991;553-556.
14. Rotness J.S., Iversen J.G. Thapsigargin reveals evidence for fMLP-insensitive calcium pools in human leukocytes. Cell Calcium. 13:1992;487-500.
15. 2+ entry in human neutrophils induced by thapsigargin. Cell Calcium. 10:1989;477-490.
16. Meshulam T., Proto P., Diamond R.D., Melnick D.A. Calcium modulation and chemotactic response Divergent stimulation of neutrophil chemotaxis and cytosolic calcium response by the chemotactic peptide receptor . J Immunol. 137:1986;1954-1960.
17. Elferink J.G., Deierkauf M. The effect of quin2 on chemotaxis by polymorphonuclear leukocytes. Biochim Biophys Acta. 846:1985;364-369.
18. Marks P.W., Maxfield F.R. Transient increases in cytosolic free calcium appear to be required for the migration of adherent human neutrophils. J Cell Biol. 110:1990;43-51.
19. Elferink J.G., de Koster B.M., Boonen G.J., de Priester W. Inhibition of neutrophil chemotaxis by purinoceptor agonists. Arch Int Pharmacodyn Ther. 317:1992;93-106.
20. Zigmond S.H., Hirsch J.G. Effects of cytochalasin B on polymorphonuclear leucocyte locomotion, phagocytosis and glycolysis. Exp Cell Res. 73:1972;383-393.
21. Kaplan S.S., Zdziarski U.E., Kuhns D.B., Basford R.E. Inhibition of cell movement and associated changes by hexachlorocyclohexanes due to unregulated intracellular calcium increases. Blood. 71:1988;677-683.
22. Wilkinson P.C. Leucocyte locomotion and chemotaxis. The influence of divalent cations and cation ionophores. Exp Cell Res. 93:1975;420-426.
23. Elferink J.G., de Koster B.M. Ryanodine as inhibitor of chemotactic peptide-induced chemotaxis in human neutrophils. Biochem Pharmacol. 50:1995;975-979.
24. Walters J.D., Miller T.J., Cario A.C., Beck F.M., Marucha P.T. Polyamines found in the gingival fluid inhibit chemotaxis by human polymorphonuclear leukocytes in vitro. J Periodontol. 66:1995;274-278.
25. Borish L., O'Reilly D., Klempner M.S., Rocklin R.E. Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine. J Immunol. 137:1986;1897-1903.
26. Boonen G.J., VanSteveninck J., Elferink J.G.R. Strontium and barium induce exocytosis in electropermeabilized neutrophils. Biochim Biophys Acta. 1175:1993;155-160.
27. Boyden S.V. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J Exp Med. 115:1962;453-466.
28. Zigmond S.H., Hirsch J.G. Leukocyte locomotion and chemotaxis. New methods for evaluation and demonstration of a cell-derived chemotactic factor. J Exp Med. 137:1973;387-410.
29. Wright T.M., Hoffman R.D., Nishijima J., Jakoi L., Snyderman R., Shin H.S. Leukocyte chemoattraction by 1,2-diacylglycerol. Proc Natl Acad Sci USA. 85:1988;1869-1873.
30. Boonen G.J., de Koster B.M., VanSteveninck J., Elferink J.G. Neutrophil chemotaxis induced by the diacylglycerol kinase inhibitor R59022. Biochim Biophys Acta. 1178:1993;97-102.
31. Gabler W.L., Bullock W.W., Creamer H.R. Phorbol myristate acetate induction of chemotactic migration of human polymorphonucelar neutrophils. Inflammation. 17:1993;521-530.
32. Elferink J.G., Boonen G.J., de Koster B.M. The role of calcium in neutrophil migration The effect of calcium and calcium antagonists in electroporated neutrophils . Biochem Biophys Res Commun. 182:1992;864-869.
33. Elferink J.G., de Koster B.M. The effect of cyclic GMP and cyclic AMP on migration by electroporated human neutrophils. Eur J Pharmacol. 246:1993;157-161.
34. Harvath L., Robbins J.D., Russell A.A., Seamon K.B. cAMP and human neutrophil chemotaxis. Elevation of cAMP differentially affects chemotactic responsiveness. J Immunol. 146:1991;224-232.
35. 3+-sensitive pathway and is a partial secretagogue Involvement of pertussis-toxin-sensitive G-proteins and protein phosphatases 1/2A and 2B in the signal-transduction pathway . Biochem J. 314:1996;679-686.
36. 2+ entry pathway in human neutrophils. J Biol Chem. 268:1993;13055-13061.
37. Elferink J.G., VanUffelen B.E. The role of cyclic nucleotides in neutrophil migration. Gen Pharmacol. 27:1996;387-393.